Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

3192

Actual shortage: 254 (8%)
Anticipated shortage: 1 (0%)
Avoided shortage: 10 (0%)
Resolved: 2927 (92%)

Discontinuation Reports

435

To be discontinued: 2 (0%)
Discontinued: 410 (94%)
Reversed: 23 (5%)

Late reports

482 (13%)

Overdue reports

11 (4%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-RISPERIDONE 0.25MG TABLET Resolved 2021-05-20 2021-07-22 139749
TEVA-RISPERIDONE 0.25MG TABLET Resolved 2022-06-16 2022-09-08 162861
TEVA-RISPERIDONE 3.0MG TABLET Resolved 2022-09-07 2022-12-22 168744
TEVA-RISPERIDONE 1.0MG TABLET Resolved 2022-09-22 2022-12-22 170004
TEVA-RISPERIDONE 4MG TABLET Resolved 2022-12-01 2022-12-22 176782
TEVA-RIVAROXABAN 15MG TABLET Resolved 2024-02-15 2024-07-03 219671
TEVA-RIVAROXABAN 20MG TABLET Resolved 2024-05-09 2024-06-17 227456
TEVA-RIVAROXABAN 20MG TABLET Resolved 2024-06-27 2025-01-09 231436
TEVA-RIVAROXABAN 10MG TABLET Resolved 2025-03-06 2025-03-07 252087
TEVA-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-10 2017-09-19 9805
TEVA-RIZATRIPTAN ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-08-22 2019-09-19 92151
TEVA-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-08-22 2019-11-21 92154
TEVA-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-09-24 2020-10-30 124992
TEVA-RIZATRIPTAN ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2021-02-18 2021-04-15 134340
TEVA-RIZATRIPTAN ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2022-09-22 2023-04-28 169983
TEVA-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-02-09 2023-04-28 184213
TEVA-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-10-05 2023-11-09 206428
TEVA-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Actual shortage 2025-06-19 2025-12-11 260630
TEVA-ROPINIROLE 1MG TABLET Resolved 2020-07-23 2020-08-17 120875
TEVA-ROPINIROLE 2MG TABLET Resolved 2020-07-30 2020-08-17 121500

Showing 2581 to 2600 of 3192

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-LAMOTRIGINE 25MG TABLET Discontinued 2019-04-11 2019-04-11 81388
TEVA-LAMOTRIGINE 100MG TABLET Discontinued 2025-05-28 2025-05-28 258646
TEVA-LAMOTRIGINE 150MG TABLET Discontinued 2025-05-28 2025-05-28 258652
TEVA-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Discontinued 2025-04-25 2025-04-25 255824
TEVA-LANSOPRAZOLE 15MG CAPSULE (DELAYED RELEASE) Discontinued 2025-04-29 2025-04-29 256085
TEVA-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Discontinued 2025-05-28 2025-05-28 258507
TEVA-LANSOPRAZOLE 15MG CAPSULE (DELAYED RELEASE) Discontinued 2025-05-28 2025-05-28 258510
TEVA-LATANOPROST 50MCG SOLUTION Discontinued 2020-07-10 2020-07-10 120009
TEVA-LEVOCARBIDOPA 25MG 250MG TABLET Discontinued 2025-05-28 2025-05-28 258625
TEVA-LISINOPRIL (TYPE P) 20MG TABLET Discontinued 2018-10-12 2018-10-12 63978
TEVA-LISINOPRIL (TYPE P) 5MG TABLET Discontinued 2018-10-19 2018-10-19 64909
TEVA-LISINOPRIL (TYPE P) 5MG TABLET Discontinued 2019-04-11 2019-04-11 81298
TEVA-LISINOPRIL (TYPE P) 10MG TABLET Discontinued 2019-04-11 2019-04-11 81400
TEVA-LISINOPRIL (TYPE P) 20MG TABLET Discontinued 2020-01-24 2020-01-24 104257
TEVA-LISINOPRIL (TYPE Z) 10MG TABLET Discontinued 2019-08-15 2019-08-15 91648
TEVA-LISINOPRIL (TYPE Z) 20MG TABLET Discontinued 2025-05-28 2025-05-28 258694
TEVA-LISINOPRIL (TYPE Z) 5MG TABLET Discontinued 2025-05-28 2025-05-28 258699
TEVA-LISINOPRIL/HCTZ (TYPE P) 12.5MG 10MG TABLET Discontinued 2018-10-12 2018-10-12 63975
TEVA-LISINOPRIL/HCTZ (TYPE P) 12.5MG 20MG TABLET Discontinued 2019-04-11 2019-04-11 81301
TEVA-LISINOPRIL/HCTZ (TYPE P) 25MG 20MG TABLET Discontinued 2019-04-11 2019-04-11 81368

Showing 261 to 280 of 435